Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

(NASDAQ:TWST) SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one meetings at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, 2025. T